Established in August 1999, Xi'an Deli Biochemical Co., Ltd. is a high-tech enterprise specializing in research, development, production and sales of new pharmaceutical excipients.
The core technology of the company has been appraised as international advanced level by Shaanxi Provincial Science and Technology Commission.
In 2000, the company obtained the technology innovation fund of the Ministry of science and technology of RMB 700000 for free.
In 2001, the company's leading product, hydroxypropyl beta cyclodextrin project was listed in Xi'an torch plan. In the same year, hydroxypropyl beta cyclodextrin as a pharmaceutical excipient passed the technical evaluation of the State Drug Administration (SDA).
On September 14, 2002, our company obtained the clinical approval (approval No.: 2002fl0001).
On July 23, 2007, it was reported to SFDA for production. The drug evaluation center of the State Food and Drug Administration completed the technical evaluation on January 23, 2009 and submitted it to the State Food and Drug Administration for approval.
On February 27, 2009, new drug certificate (Certificate No.: Guoyao Zhengzi f20090001) and drug registration approval document (approval No.: 2009s00608) and drug approval document No. (guoyaozhunzi f20090001) were issued.
In 2010, the drug production license was obtained through the examination and approval of the drug supervision department.
Our company is the first pharmaceutical excipient manufacturer with injection approval and production license in China. In 2011, it obtained the registration approval document of pharmaceutical excipients for oral use [shaanshiyao Zhunzi (f) 61110001].
The company has an annual output of 150 tons of hydroxypropyl beta cyclodextrin production line, which can provide customers with different specifications.
The quality of our products meets the requirements of Chinese Pharmacopoeia, American Pharmacopoeia and European Pharmacopoeia, and can provide personalized solutions for customers.
At the same time, our products are also sold to North America, Europe and many other countries, and have been highly recognized
